You are here: Industry Insights > Studies

News List

Reistone Announces First Patient Dosed in Two Phase II Studies of SHR0302 americanpharmaceuticalreview
June 20, 2019
Reistone Biopharma announced dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively.
SCYNEXIS Completes Chronic Nonclinical Toxicology Studies Supporting Long-Term Administration of Ibrexafungerp americanpharmaceuticalreview
May 31, 2019
SCYNEXIS announced the company has completed the nonclinical toxicology evaluations that are required by regulatory authorities, including the U.S. Food and Drug Administration (FDA), to support long-term administration in human clinical trials.
Less-Invasive Surgery for Cervical Cancer May Bring More Risks, Studies Find drugs
November 01, 2018
Less-Invasive Surgery for Cervical Cancer May Bring More Risks, Studies Find
TSO3 Details Results of Prion Inactivation Studies biospace
April 27, 2018
TSO3 Inc. today announced that an independent laboratory has completed studies demonstrating the efficacy of the STERIZONE® VP4 Sterilizer for inactivation of prions.